CD44 and cholangiocarcinoma: Additionally, DNA lesions were significantly increased in O. viverrini-associated cholangiocarcinoma patients with high expressions of CD133 and/or Oct3/4 in their tumor tissues, whereas there were no significant differences of DNA lesions, in patients, between CD44 and/or OV6-positive and negative tumor tissues [101].